Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

High-quality validation studies are needed to improve alopecia areata patient-reported outcome measures.

High-resolution MRI can distinguish between tertiary androgenetic alopecia and severe alopecia areata by measuring scalp and tissue thickness and hair follicle depth.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

Trichoscopy helps diagnose and monitor hair and scalp problems without needing many biopsies.

Compound glycyrrhizin with conventional treatments is effective and safe for hair regrowth in alopecia areata.

Obesity and bariatric surgery can cause hair thinning and temporary hair loss due to nutritional deficiencies and stress.

Genetic variations affecting skin structure play a key role in severe acne.

Children with early graying hair might have lower levels of certain nutrients like zinc, magnesium, and Vitamin B12.

Laser treatment, especially when combined with other therapies, is effective for hair regrowth in alopecia areata.

Ophiasis mainly affects females, lasts longer, and has lower regrowth rates, with a new classification system helping predict treatment response.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

The nervous system helps control stem cell behavior and immune responses, affecting tissue repair and maintenance.

Lactoferrin may improve hair and skin health by reducing inflammation and promoting healing.

AI improves accuracy and consistency in diagnosing male pattern hair loss.

Botulinum toxin is used in skin care for cosmetic and medical purposes.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

Smoking increases early hair loss risk in men; quitting may help prevent it.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Clinical hirsutism can help predict high androgen levels in women.

There is no significant link between metabolic syndrome and alopecia areata.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Lash ptosis is more common and severe in people with congenital eyelid droop than in those with acquired eyelid droop or without eyelid droop.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.